UBS Group’s Acruence Active Hedge US Equity ETF XVOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.02K Buy
+359
New +$8.34K ﹤0.01% 8529
2024
Q4
Sell
-705
Closed -$15.4K 10488
2024
Q3
$15.4K Buy
+705
New +$14.9K ﹤0.01% 7514
2024
Q2
Sell
-78
Closed -$1.62K 10199
2024
Q1
$1.62K Buy
+78
New +$1.49K ﹤0.01% 8099
2023
Q3
Sell
-2
Closed -$37 10036
2023
Q2
$37 Buy
+2
New +$36 ﹤0.01% 8635
2022
Q4
Sell
-908
Closed -$15K 11210
2022
Q3
$15K Buy
908
+1
+0.1% +$19 ﹤0.01% 7833
2022
Q2
$16K Buy
907
+312
+52% +$6.02K ﹤0.01% 7216
2022
Q1
$13K Buy
595
+578
+3,400% +$12.1K ﹤0.01% 8084
2021
Q4
$0 Sell
17
-53
-76% -$1.16K ﹤0.01% 10782
2021
Q3
$1K Buy
+70
New +$1.48K ﹤0.01% 9263

Other funds holding XVOL

UBS Group's XVOL Position: Q1 2026 in Review

UBS Group opened a new position in Acruence Active Hedge US Equity ETF (XVOL) in Q1 2026: 359 shares worth $8.02K. The stake represents ﹤0.01% of the portfolio and ranks #8529 among its holdings. This is a return to the name: UBS Group previously reported a position in XVOL as recently as Q3 2024.

UBS Group first reported a position in XVOL in Q3 2021 and has held it in 9 quarters since. The position peaked at $16K in Q2 2022. 3 funds tracked by Wall St. Rank hold XVOL as of Q1 2026.

  • UBS Group held 359 shares of Acruence Active Hedge US Equity ETF worth $8.02K as of Q1 2026.
  • Acruence Active Hedge US Equity ETF was a new UBS Group position in Q1 2026.
  • Acruence Active Hedge US Equity ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8529 holding.
  • UBS Group first reported a position in Acruence Active Hedge US Equity ETF in Q3 2021 and has held it in 9 quarters since.
  • UBS Group's Acruence Active Hedge US Equity ETF position peaked at $16K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Acruence Active Hedge US Equity ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.